Clinical Trial Update: Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intravitreal aflibercept for improving diabetic retinopathy using real-time objective imaging; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED